INDIGO Biosciences Expands Reporter Assay Capabilities with New Transrepression Assay Services

New service offering enables GR/NF-κB transrepression studies to support deeper mechanism-of-action insight in drug ...
WATE 6 On Your Side

INDIGO Biosciences Introduces Cell-Based Luciferase Reporter Assay for Human c-MET / Hepatocyte Growth Factor Receptor

A New Sensitive, Time-Saving Assay for Preclinical Research of Cancer, Fibrosis, and Inflammatory Diseases STATE COLLEGE, PENNSYLVANIA, UNITED STATES, June 4, 2024 ...
Sarasota Herald-Tribune

INDIGO Biosciences Launches AMY1 and AMY3 Receptor Reporter Assays for Metabolic and Neuroendocrine Research

STATE COLLEGE, PA, UNITED STATES, January 15, 2026 /EINPresswire.com/ — INDIGO Biosciences, a premier provider of cell-based reporter assay solutions, has announced ...
Reno Gazette-Journal

INDIGO Biosciences Launches CHRM1 (Cholinergic Receptor, Muscarinic 1) Reporter Assays for Cognitive Drug Discovery

STATE COLLEGE, PA, UNITED STATES, March 19, 2026 /EINPresswire.com/ — INDIGO Biosciences, a leading provider of cell-based reporter assay solutions, today announced ...
EurekAlert!

Simple and cost-effective reporter assay for evaluating chemical-induced epigenetic changes

Chemicals used in different applications induce genetic and epigenetic aberrations implicated in various diseases, including cancer. Researchers from Japan have developed a cell-based reporter assay ...